Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
36
Number of overlapping holdings
69.2%
% of BBP's 55 holdings also in XBI
27.7%
% of XBI's 131 holdings also in BBP
Overlap by Weight
Sector Drift (BBP minus XBI)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBP |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
ROIVANT SCIENCES LTD. | 1.9% | 1.2% | 1.2% |
 |
EXELIXIS INC | 1.7% | 1.1% | 1.1% |
|
ALNYLAM PHARMACEUTICALS INC | 1.5% | 1.1% | 1.1% |
|
SAREPTA THERAPEUTICS INC | 2.4% | 1.1% | 1.1% |
|
BIOMARIN PHARMACEUTICAL INC | 1.6% | 1.1% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
BBP Overweight Relative to XBI
|
TARSUS PHARMACEUTICALS, INC. | 3.5% |
|
LEXICON PHARMACEUTICALS, INC. | 3.4% |
|
AMYLYX PHARMACEUTICALS, INC. | 2.3% |
|
ASCENDIS PHARMA A/S | 2.3% |
|
LIGAND PHARMACEUTICALS-CL B | 2.1% |
|
AXSOME THERAPEUTICS, INC. | 2.0% |
|
KINIKSA PHARMACEUTICALS LTD. CLASS A | 2.0% |
|
INTRA-CELLULAR THERAPIES INC | 2.0% |
|
ADMA BIOLOGICS, INC. | 1.9% |
|
LEGEND BIOTECH CORPORATION SPONSORED | 1.9% |
BBP Underweight Relative to XBI
|
EXACT SCIENCES CORP | -1.2% |
|
CRINETICS PHARMACEUTICALS INC | -1.2% |
|
CYTOKINETICS INC | -1.2% |
|
NATERA INC | -1.2% |
|
VIKING THERAPEUTICS, INC. | -1.1% |
|
KRYSTAL BIOTECH, INC. | -1.1% |
|
CEREVEL THERAPEUTICS HOLDINGS INC | -1.1% |
|
ARCUTIS BIOTHERAPEUTICS INC | -1.1% |
|
IMMUNOVANT INC | -1.1% |
|
DYNE THERAPEUTICS INC | -1.1% |